Penn Medicine aims to increase the pipeline of future nurses in Philadelphia through a new program that offers education and employment opportunities for high school and college students interested in nursing, the organization said Jan. 3.
Category: ROOT
$84M paid for Providence office portfolio
Renton, Wash.-based Providence has sold an office portfolio to Seattle Children’s Hospital for $84 million, globest.com reported Dec. 30.
Meritus Health names new chief medical officer, associate dean for proposed school of osteopathic medicine
Dr. Anand Budi has been promoted to chief medical officer at Hagerstown, Md.-based Meritus Medical Center. He has been serving as the hospital’s associate CMO, according to a Meritus news release.
The remaining efficacy of omicron boosters: 5 studies
As researchers study how well the omicron-targeting boosters work against the now-dominant subvariant XBB.1.5, here’s what five recent studies found:
Judge orders vendor to return EHR data to CommonSpirit Health
A federal judge has granted Chicago-based CommonSpirit Health a temporary restraining order against a Texas healthcare data company, requiring it to return patient health information the health system had hired it to process and archive.
New omicron strain now makes up 40% of US cases: 3 notes
In one week, the prevalence of XBB.1.5 — an offshoot of omicron subvariant XBB — more than doubled in the U.S., according to the latest CDC estimates.
Strike set at 7 NYC hospitals
Members of the New York State Nurses Association are set to strike Jan. 9 at seven New York City hospitals unless contracts are reached.
New Orleans to relieve $130M in medical debt
The New Orleans City Council included a line item in the city’s 2023 budget aimed at eliminating up to $130 million in medical debt, the Louisiana Illuminator reported Jan. 2.
Ransomware group appears to apologize for attack on pediatric hospital
LockBit, a cybercriminal organization, appeared to issue an apology and offer a decryption key after it attacked SickKids, a major pediatric hospital in Toronto, Techradar reported Jan. 3.
FDA approves expanded use of cancer drug Tecentriq
The FDA recently approved an immunotherapy drug called Tecentriq (atezolizumab) for patients ages 2 and up who have advanced alveolar soft part sarcoma that has spread to other parts of the body or cannot be removed by surgery, U.S. News & World Report…
